Rare cancers and unusual clinical presentations often challenge the diagnostic and therapeutic expertise of healthcare teams. These cases frequently involve conditions with limited research, such as neuroendocrine tumors or angiosarcomas, which require advanced diagnostic tools like molecular imaging and genomic analysis. They provide a unique opportunity to study atypical tumor behaviors and rare genetic mutations, paving the way for innovative research and treatment approaches. Sharing such cases raises awareness among clinicians, ensuring timely identification and optimal care for patients. Moreover, these presentations inspire the development of novel diagnostic methods and targeted therapies, contributing to a deeper understanding of cancer biology and offering hope to those facing rare cancer diagnoses.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States